BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14599634)

  • 1. Coronary restenosis: a review of mechanisms and management.
    Rajagopal V; Rockson SG
    Am J Med; 2003 Nov; 115(7):547-53. PubMed ID: 14599634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
    Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
    Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular brachytherapy: a review of the current vascular biology.
    Apisarnthanarax S; Chougule P
    Am J Clin Oncol; 2003 Jun; 26(3):e13-21. PubMed ID: 12796611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated intracoronary beta radiation for recurrent in-stent restenosis.
    De Benedetti E; Latchem D; Roguelov C; Coucke P; Seydoux C; Goy JJ; Urban P; Eeckhout E
    Catheter Cardiovasc Interv; 2002 Feb; 55(2):233-6. PubMed ID: 11835654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury.
    Scott NA
    Adv Drug Deliv Rev; 2006 Jun; 58(3):358-76. PubMed ID: 16733073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
    Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late results (>10 years) of intracoronary beta brachytherapy for diffuse in-stent restenosis.
    Seabra Gomes R; de Araújo Gonçalves P; Campante Teles R; de Sousa Almeida M
    Rev Port Cardiol; 2014 Oct; 33(10):609-16. PubMed ID: 25304770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
    Sheppard R; Eisenberg MJ; Donath D; Meerkin D
    Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial angioscopic findings after successful intracoronary brachytherapy for in-stent restenosis.
    Okada M; Tamai H; Kyo E; Kosuga K; Hata T; Nakamura T; Fujita S; Tsuji T; Takeda S; Masunaga N; Motohara S; Uehata H
    Am J Cardiol; 2006 Jan; 97(1):21-5. PubMed ID: 16377277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat radiation for recurrent in-stent restenosis in patients who failed initial brachytherapy.
    Kuchulakanti P; Waksman R
    J Invasive Cardiol; 2003 Dec; 15(12):732-4; quiz 735. PubMed ID: 14660831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debulking for in-stent restenosis in the brachytherapy era: does it still have a role?
    Tuli A; Subramaniyam V; Bakir S; Block PC; Crocker IR
    J Invasive Cardiol; 2003 Apr; 15(4):209-12. PubMed ID: 12668849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary beta-radiation for the treatment of patients at very high risk for recurrence of in-stent restenosis: a single center experience.
    Parenti DZ; Marsico F; Tosi G; Catalano G; Maiello L; Milone F; Carcagnì A; Pron PG; Orecchia R; Presbitero P
    Ital Heart J; 2003 Mar; 4(3):199-204. PubMed ID: 12784747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
    Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
    J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
    Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
    JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary brachytherapy. Treatment of in-stent restenosis with the Beta-Cath system. Initial experience in Latin America.
    Muñoz JS; Feres F; Abizaid AC; Mattos LA; Staico R; Centemero M; Tanajura LF; Pinto I; Sousa AG; Sousa JE
    Arq Bras Cardiol; 2004 Jul; 83(1):63-8; 57-62. PubMed ID: 15322668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.